Oppenheimer & Co. Inc. Sells 3,442 Shares of Abbott Laborato

Oppenheimer & Co. Inc. lowered its position in Abbott Laboratories (NYSE:ABT – Free Report) by 3.2% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 103,199 shares of the healthcare product maker’s stock after selling 3,442 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Abbott Laboratories were worth $11,359,000 at the end […]

Related Keywords

Canada , Wellington , New Zealand General , New Zealand , Roberte Funck , Lisad Earnhardt , , Wellington Management Group , Abbott Laboratories , Barclays , Norges Bank , Securities Exchange Commission , Capital International Investors , Capital Research Global Investors , Oppenheimer Co , Northern Trust Corp , Citigroup , Goldman Sachs Group , Royal Bank , Free Report , Research Global Investors , International Investors , Management Group , Trust Corp , Laboratories Trading Down , Get Free Report , Exchange Commission , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products , Visit Holdingschannel , Abbott Laboratories Daily ,